ERYTECH to Participate in Upcoming Virtual Investor Conferences in March

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the following conferences in the month of March and participate in select one-on-one investor meetings alongside members of the senior management.

Menu